Vertaling van "european trial on reduction of cardiac events " (Nederlands → Frans) :

J. Hypertension 21, 1771-1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.
J. Hypertension 21, 1771- 1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.

31. Auerbach AD, Goldman L. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review.
30. Auerbach AD, Goldman L. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review.

Results from the Japanese KYOTO HEART study, presented in September at the European Society of Cardiology Congress, demonstrated that the addition of Diovan to a non-ARB-based treatment regimen for high blood pressure provided a significant 45% relative risk reduction in cardiovascular events, including stroke, over a conventional non-ARB treatment regimen.
Les résultats de l’étude japonaise KYOTO HEART, présentés au Congrès de la Société Européenne de Cardiologie, ont prouvé que l’adjonction de Diovan lors d’un traitement contre l’hypertension non basé sur les ARA a conduit à une réduction importante de 45% du risque relatif d’accidents cardiovasculaires, notamment cérébraux, par rapport à un traitement non ARA conventionnel.